Efficacy of Brucella Vaccines in Sheep: A Systematic Review and Meta-Analysis
- PMID: 40303105
- PMCID: PMC12016899
- DOI: 10.1155/2024/5524768
Efficacy of Brucella Vaccines in Sheep: A Systematic Review and Meta-Analysis
Abstract
Background: Brucellosis is a major worldwide public health problem with economic and zoonotic implications. Despite the importance of vaccines in preventing brucellosis, no previous systematic evaluation of vaccination in sheep has been conducted.
Materials and methods: Articles were searched in databases such as PubMed, Science Direct, Cochrane, VIP, Wan Fang, and CNKI by screening the articles, and articles reporting Brucella vaccination in sheep were included in the study. Meta-analysis was performed using random effects models to calculate pooled risk ratios for vaccines and to calculate vaccine effectiveness.
Results: A total of 2,605 articles were retrieved, and 17 articles were obtained through screening for analysis. The effectiveness of vaccination was 65% (RR = 0.35, 95% CI: 0.27-0.36; VE = 65%), with the M5 vaccine being significantly more effective at 84% (RR = 0.1587, 95% CI: 0.0256-0.9858; VE = 84%) than the other vaccines, and intramuscular injection could be the best route of immunization. Rev.1 was indicated for female sheep, especially for pregnant ewes (RR = 0.2016, 95% CI: 0.1139-0.3569; VE = 80%), and for reduced abortions (RR = 0.0978, 95% CI: 0.0459-0.2085).
Conclusion: This meta-analysis was conducted to identify the relevant factors affecting vaccine efficacy. We recommend that sheep be inoculated intramuscularly with Rev.1, different inoculation protocols be adopted for sheep of different ages, and pregnant ewes be inoculated with Rev.1 to prevent abortion.
Copyright © 2024 Lian-Min Li et al.
Conflict of interest statement
The authors declare that they have no conflicts of interest.
Figures






















Similar articles
-
Vaccine Candidate Brucella melitensis 16MΔvjbR Is Safe in a Pregnant Sheep Model and Confers Protection.mSphere. 2020 May 13;5(3):e00120-20. doi: 10.1128/mSphere.00120-20. mSphere. 2020. PMID: 32404509 Free PMC article.
-
Comparison of the efficacy of Brucella abortus strain RB51 and Brucella melitensis Rev. 1 live vaccines against experimental infection with Brucella melitensis in pregnant ewes.Rev Sci Tech. 2001 Dec;20(3):741-7. doi: 10.20506/rst.20.3.1305. Rev Sci Tech. 2001. PMID: 11732416 Clinical Trial.
-
A review of the use of B. melitensis Rev 1 vaccine in adult sheep and goats.Prev Vet Med. 1997 Aug;31(3-4):275-83. doi: 10.1016/s0167-5877(96)01110-5. Prev Vet Med. 1997. PMID: 9234451 Review.
-
[Immunization of ewes and she-goats against experimental Brucella melitensis infection. A comparison of REV 1 and H 38 vaccines].Dev Biol Stand. 1984;56:629-42. Dev Biol Stand. 1984. PMID: 6489637 French. No abstract available.
-
Acellular vaccines for ovine brucellosis: a safer alternative against a worldwide disease.Expert Rev Vaccines. 2012 Jan;11(1):87-95. doi: 10.1586/erv.11.172. Expert Rev Vaccines. 2012. PMID: 22149711 Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources